Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 14, 2025 13:57 ET | Source: KuicK Research

US FDA Orphan Drug Rare Disease Market Clinical Trials Drug Sales Insight 2030

Delhi, May 14, 2025 (GLOBE NEWSWIRE) -- US Orphan Designated Drugs Market Opportunity, Drugs Sales, Price, Dosage and Clinical Trials Insight 2030 Report Offering and Highlights: US Orphan...
May 14, 2025 08:30 ET | Source: Surrozen, Inc.

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway

Surrozen Granted Patent from U.S. Patent and Trademark Office Directed to Antibody-Based Molecules Targeting Key Receptors in the Wnt Pathway
May 14, 2025 08:30 ET | Source: SAIHEAT Limited

SAIHEAT Secures Patent for Innovative Control Rod Drive Mechanism in Small Modular Reactor Technology

SINGAPORE, May 14, 2025 (GLOBE NEWSWIRE) -- SAIHEAT Limited (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW) today announced it has received the Invention Patent Authorization Notice for its...
May 13, 2025 08:00 ET | Source: Reflect Scientific Inc.

Reflect Scientific Secures Patents for Data Center Cooling with Cryogenic Innovation

Reflect Scientific earned a U.S. patent for a cryogenic system that rapidly cools data centers, addressing AI and cloud computing heat challenges.
May 12, 2025 16:01 ET | Source: Editas Medicine, Inc.

Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Remands CRISPR Patent Interference to Patent Trial and Appeal Board

CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company, today announced that the U.S. Court of Appeals for the Federal Circuit...
May 12, 2025 07:00 ET | Source: EnviroGold Global Limited

EnviroGold Global Consolidates Process Development Technology and Strengthens IP Portfolio with New Patent Filing

EnviroGold announces the filing of a new PCT patent application with IP Australia
May 12, 2025 06:00 ET | Source: Liquidia Corporation

Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics

New litigation filed against Liquidia in U.S. District Court for the Middle District of North Carolina alleges infringement of UTHR’s ‘782 patent and seeks to enjoin Liquidia from commercializing...
May 12, 2025 04:00 ET | Source: AKAMPION

Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate

ODD granted for the treatment of soft tissue sarcomas (STS)Thermosome adds 4 patents to its growing patent estate Munich, Germany – May 12, 2025 – Thermosome, a drug development company focused on...
May 09, 2025 08:30 ET | Source: Conduit Pharmaceuticals

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
May 07, 2025 08:30 ET | Source: Orchestra BioMed Holdings, Inc.

Orchestra BioMed’s AVIM Therapy Global Intellectual Property Estate Reaches 137 Issued Patents for the Treatment of Hypertension and Heart Failure

Secured ten new fully-issued patents related to hypertension treatment during last 12 months, bringing global issued patent estate total for this condition to 120 patentsPatent estate covering...